Home > A. Molecular pathology > CDs > CD79A

CD79A

MIM.112205 19q13.2

Monday 19 December 2005

CD79a

CD79A encodes the Ig-alpha protein of the B-cell antigen receptor, that also includes Ig-beta protein, surface immunoglobulin.

Expression in normal cells

- expressed early in B-cell differentiation (often positive when mature B-cell markers are negative)
- plasma cells
- human thymus and thymoma

  • low-level expression of CD79a is common in thymocytes and thymoma-associated lymphocytes. (12115880)
  • CD79a is expressed weakly and transiently in immature T-lineage cells. (12115880)

Expression in tumors

- acute lymphoblastic leukemia

  • precursor T-cell lymphoblastic lymphoma (12115880)
    • CD79a-positive neoplastic cells exhibite a phenotype and genotype characteristic of an early stage of T cell differentiation.

- CD20-negative B-cell proliferations

  • post-rituximab CD20-negative PTLDs (CD20- PTLDs)
  • CD20- small B-cell lymphoproliferative disorders

- B cell lymphomas

  • more consistently preserved in infarcted lymphomas than CD20

- lymphocyte-predominant Hodgkin lymphoma
- classic Hodgkin lymphoma